tiprankstipranks
Advertisement
Advertisement

UPL Confirms Rights Issue Proceeds Fully Aligned With Stated Objectives

Story Highlights
  • UPL’s monitoring report confirms rights issue funds were used exactly as planned.
  • CARE Ratings’ review finds no deviation in UPL’s utilisation of ₹3,377.74 crore proceeds.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
UPL Confirms Rights Issue Proceeds Fully Aligned With Stated Objectives

Claim 30% Off TipRanks

UPL Limited ( (IN:UPL) ) has shared an update.

UPL Limited has disclosed that the proceeds from its ₹3,377.74 crore rights issue have been utilised in line with stated objectives, with no variation or deviation reported for the quarter and nine-month period ended December 31, 2025. A Monitoring Agency Report issued by CARE Ratings Limited, in accordance with SEBI regulations, confirms compliant use of funds, reinforcing transparency for investors and signalling adherence to the company’s capital allocation commitments.

More about UPL Limited

UPL Limited is an India-headquartered company operating in the chemicals and agro-inputs space, serving agricultural and related sectors globally with a portfolio that includes crop protection and specialty chemical products. The company is listed on the BSE and NSE and targets both domestic and international markets through its diversified agri-solutions offerings.

Average Trading Volume: 117,004

Technical Sentiment Signal: Buy

Current Market Cap: 594.3B INR

Find detailed analytics on UPL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1